214964-87-1

Basic information

• Product Name: tert-Butyl N-[2-(3-bromophenyl)propan-2-yl]carbamate
• Synonyms: tert-Butyl N-[2-(3-bromophenyl)propan-2-yl]carbamate;TERT-BUTYL (2-(3-BROMOPHENYL)PROPAN-2-YL)CARBAMATE
• CAS NO: 214964-87-1
• Molecular Formula: C₁₄H₂₀BrNO₂
• Molecular Weight: 314.2181
• Mol File: 214964-87-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-Butyl N-[2-(3-bromophenyl)propan-2-yl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl N-[2-(3-bromophenyl)propan-2-yl]carbamate(214964-87-1)
• EPA Substance Registry System: tert-Butyl N-[2-(3-bromophenyl)propan-2-yl]carbamate(214964-87-1)

Safety Data

• Hazardous Substances Data: 214964-87-1(Hazardous Substances Data)

Upstream product

• 74702-93-5 2-(3-bromophenyl)propan-2-amine 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1415502-44-1 methyl 3-{2-[(tert-butoxycarbonyl)amino]propan-2-yl}benzoate 

Relevant articles and documents

NOVEL NON-SYSTEMIC TGR5 AGONISTS

The present invention relates to sulfonamide compounds of formula (I) and formula (II), or a pharmaceutically acceptable salt thereof. The present sulfonamide compounds are useful non-systemic TGR5 agonists that can be used to treat diabetic diseases in human. The present invention provides a pharmaceutical composition containing sulfonamide compounds of formula (I) and formula (II) and a method of making as well as a method of using same in treating patients inflicted with metabolic disorders by administering same. The compounds of the present invention may be used in combination with additional anti-diabetic drugs.

Pyrrolopyrimidines and Pyrrolopyridines

Compounds of formula I in free or salt or solvate form, wherein X, T1, T3 and T4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.